GILEAD SCIENCES, INC. — Director's Dealing 2018

Jan 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2018-01-16

Reporting Person: Meyers James R (EVP Worldwide Commercial Ops)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-16	Common Stock	M	100000	$21.575	Acquired	102715	Direct
2018-01-16	Common Stock	S	75157	$79.9961	Disposed	27558	Direct
2018-01-16	Common Stock	S	24843	$80.9925	Disposed	2715	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-16	Non-qualified Stock Option (Right to Buy)	$21.575	M	100000	Disposed	2018-01-30	Common Stock (100000)	Direct

Footnotes

F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.

F2: The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.

F3: Sale prices reported for the transactions reported here range from $79.56 to $80.56. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.

F4: Sale prices reported for the transactions reported here range from $80.57 to $81.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.